Accelerate Diagnostics

AXDX NASDAQ
Overview Stats Financials News

Quarterly Financials

Values in thousands 2024-03-31 2023-12-31 2023-09-30 2023-06-30
Revenue $2,921 $3,000 $3,299 $2,921
Gross Profit 723 606 107 799
EBITDA -10,156 -7,580 -13,616 -11,475
EBIT -8,400 -14,433 -12,290
Net Income -16,965 -13,000 910 -25,980
Net Change In Cash 2,921 3,000 3,299 2,921
Cost of Revenue -100
Free Cash Flow -8,452 -7,865 -9,011 -10,977
Cash 14,606 12,138 20,162 29,282
Basic Shares 19,216 14,569 14,553 11,009

Annual Financials

Values in thousands 2023-12-31 2022-12-31 2021-12-31 2020-12-31
Revenue $12,059 $12,752 $11,782 $11,165
Gross Profit 2,550 3,303 -381 4,459
EBITDA -50,774 -59,481 -68,974 -59,908
EBIT -54,028 -62,805 -71,560 -63,700
Net Income -61,618 -62,493 -77,702 -78,208
Net Change In Cash 12,059 12,752 11,782 11,165
Cost of Revenue 4,117 -25,233
Free Cash Flow -41,230 -49,282 -47,926 -51,756
Cash 12,138 34,905 39,898 35,781
Basic Shares 12,477 6,172 6,172 5,601

Earnings Calls

Quarter EPS
2024-03-31 -$0.88
2023-12-31 -$0.81
2023-09-30 $0.14
2023-06-30 -$1.31